Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's choice to lead Medicare and Medicaid services. But this could mean a potential ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
Unfortunately, Medicare is forbidden to cover weight loss drugs for obesity unless patients possess another medical condition such as diabetes or cardiovascular disease. This policy prevents ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.
While the outcomes can be positive, Consumer Reports warns there are important considerations, especially for older adults, ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.